Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 207 (1-2) , 71-76
- https://doi.org/10.1016/s0022-510x(02)00398-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endotheliumBrain, 2000
- Tissue inhibitors of metalloproteinases: evolution, structure and functionBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by OligodendrocytesJournal of Neuroscience, 1999
- Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemiaPublished by Elsevier ,1999
- Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosisBrain, 1998
- Matrix metalloproteinases contribute to the blood—brain barrier disruption during bacterial meningitisAnnals of Neurology, 1998
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluidJournal of Neuroimmunology, 1998
- Matrix metalloproteinases and diseases of the CNSTrends in Neurosciences, 1998
- Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40)Journal of Neuroscience, 1996
- Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and NeuronsNeuroimmunomodulation, 1996